📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

New and emerging treatments for schizophrenia: a narrative review of their pharmacology, efficacy and side effect profile relative to established antipsychotics. (2022)

First Author: Lobo MC

Attributed to: MICA: Targeting neuro-inflammation in Schizophrenia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.neubiorev.2021.11.032

PubMed Identifier: 34838528

Publication URI: http://europepmc.org/abstract/MED/34838528

Type: Journal Article/Review

Volume: 132

Parent Publication: Neuroscience and biobehavioral reviews

ISSN: 0149-7634